← All trials
NCT03440125
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2016
- Primary completion
- Nov 15, 2016
- Completion date
- Dec 15, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PrimorskaLead sponsor
- Wilhelminenspital der Stadt WienCollaborator
- AbecmaCollaborator
- University of PrimorskaReponsible party - principal investigator
- University of PrimorskaOverall official - principal investigator
- Ludwig Boltzmann InstituteCollaborator
- S2P, Science to Practice, Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.